Quadrant Capital Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Buy |
45,499
+42,893
| +1,646% | +$483K | 0.02% | 862 |
|
|
2025
Q1 | $26.3K | Buy |
2,606
+1,694
| +186% | +$17.1K | ﹤0.01% | 1950 |
|
|
2024
Q4 | $10.8K | Hold |
912
| – | – | ﹤0.01% | 2099 |
|
|
2024
Q3 | $10.5K | Hold |
912
| – | – | ﹤0.01% | 2130 |
|
|
2024
Q2 | $9.64K | Hold |
912
| – | – | ﹤0.01% | 2134 |
|
|
2024
Q1 | $9.61K | Hold |
912
| – | – | ﹤0.01% | 2123 |
|
|
2023
Q4 | $10.2K | Buy |
912
+613
| +205% | +$6.88K | ﹤0.01% | 2058 |
|
|
2023
Q3 | $3.49K | Buy |
299
+168
| +128% | +$1.96K | ﹤0.01% | 2262 |
|
|
2023
Q2 | $1.32K | Hold |
131
| – | – | ﹤0.01% | 2475 |
|
|
2023
Q1 | $967 | Hold |
131
| – | – | ﹤0.01% | 2543 |
|
|
2022
Q4 | $1.05K | Buy |
+131
| New | +$1.05K | ﹤0.01% | 2539 |
|